We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Transgene SA | EU:TNG | Euronext | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.686 | 0.685 | 0.75 | 0.00 | 06:33:16 |
From Dec 2024 to Jan 2025
Strasbourg, January 7, 2025 – 06:00 pm CET
Under the liquidity contract entrusted by Transgene to Natixis Oddo BHF SCA, as of December 31, 2024, the following resources were managed through the liquidity account:
In the second half of 2024, a total of:
| Purchases | 250,777 shares | € 243,947.38 | 1,154 market transactions |
| Sales | 229 905 shares | € 230,275.17 | 1,081 market transactions |
It is recalled that when the liquidity program was initially established in 2016, the following resources were made available:
At the time the liquidity program was transferred to Natixis Oddo BHF SCA on January 2, 2020, the resources managed through the liquidity account consisted of:
Contacts
| Transgene: Lucie LARGUIER CFO +33 (0)3 88 27 91 00 investorrelations@transgene.fr |
Attachment
1 Year Transgene Chart |
1 Month Transgene Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
